Dr. Jonathan E. Velasco, MD
Claim this profileKettering Medical Center
Studies Post-Amputation Pain
Studies Phantom Limb Pain
1 reported clinical trial
1 drug studied
Affiliated Hospitals
More about Jonathan E. Velasco, MD
Clinical Trial Related9 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Jonathan E. Velasco, MD has experience with
- Altius System
Breakdown of trials Jonathan E. Velasco, MD has run
Post-Amputation Pain
Phantom Limb Pain
Residual Limb Pain
Phantom Limb Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan E. Velasco, MD specialize in?
Jonathan E. Velasco, MD focuses on Post-Amputation Pain and Phantom Limb Pain. In particular, much of their work with Post-Amputation Pain has involved treating patients, or patients who are undergoing treatment.
Is Jonathan E. Velasco, MD currently recruiting for clinical trials?
No, Jonathan E. Velasco, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Jonathan E. Velasco, MD has studied deeply?
Yes, Jonathan E. Velasco, MD has studied treatments such as Altius System.
What is the best way to schedule an appointment with Jonathan E. Velasco, MD?
Apply for one of the trials that Jonathan E. Velasco, MD is conducting.
What is the office address of Jonathan E. Velasco, MD?
The office of Jonathan E. Velasco, MD is located at: Kettering Medical Center, Springboro, Ohio 45066 United States. This is the address for their practice at the Kettering Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.